Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)

7.53
Delayed Data
As of Sep 30
 +0.08 / +1.07%
Today’s Change
6.28
Today|||52-Week Range
33.97
-67.07%
Year-to-Date

Today’s Trading

Previous close7.45
Today’s open7.52
Day’s range7.48 - 7.70
Volume79,609
Average volume (3 months)2,551,262
Market cap$1.1B
Data as of 4:02pm ET, 09/30/2022

Growth & Valuation

Earnings growth (last year)-61.39%
Earnings growth (this year)+41.43%
Earnings growth (next 5 years)--
Revenue growth (last year)-9.00%
P/E ratioNM
Price/Sales64.88
Price/Book2.22

Competitors

 Today’s
change
Today’s
% change
IMGNImmunoGen Inc+0.07+1.38%
RCKTRocket Pharmaceutica...+1.95+13.89%
NGMNGM Biopharmaceutica...+0.44+3.48%
EBSEmergent BioSolution...+0.22+1.06%
Data as of 4:01pm ET, 09/30/2022

Financials

Next reporting dateNovember 15, 2022
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$45.6M
Annual profit (last year)-$181.0M
Net profit margin-396.81%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts